30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Evanson Jeff

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
8 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -3%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Evanson Jeff's trades of Outlook Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-11 2024-03-07
B Purchase
76,890 +14.6%
317.15
US$133,858 		76,890 +14.6% 317.15 US$133,858
2023-01-24 2023-01-20
S Sale
44,646 +25.9%
143.95
US$3,928,777 		44,646 +25.9% 143.95 US$3,928,777
2023-01-19 2023-01-19
S Sale
95,273 +46.3%
347.40
US$3,774,888 		95,273 +46.3% 347.40 US$3,774,888
2023-01-19 2023-01-18
S Sale
33,738 -2.9%
1.25
US$42,172 		33,738 -2.9% 1.25 US$42,172
2023-01-19 2023-01-17
S Sale
27,162 -2.3%
1.31
US$35,582 		27,162 -2.3% 1.31 US$35,582
2021-12-06 2021-12-03
B Purchase
35,200 +3.1%
1.34
US$47,168 		35,200 +3.1% 1.34 US$47,168
2021-02-25 2021-02-23
S Sale
8,554 -0.7%
2.09
US$17,861 		8,554 -0.7% 2.09 US$17,861
2021-02-17 2021-02-12
S Sale
56,973 -4.7%
2.55
US$145,281 		56,973 -4.7% 2.55 US$145,281